Among patients with ALD and short-term abstinence, BUN and platelets are novel predictors of outcomes, along with INR. Utilizing these predictors - or recalibrating existing MELD coefficients - in this unique patient population may help refine medical selection criteria and improve utility and equity in access to early LT.
Hasjim et al. (Wed,) studied this question.